cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/76yp6j
title: Xeno-canto - Orthoptera sounds from around the world

description: This dataset covers the sounds of the Orthoptera sound collection of Xeno-canto (XC). XC is an online database that provides access to sound recordings of wildlife from around the world. The recordings are shared by a growing community of thousands of recordists from around the world, amateurs and professionals alike. The aim of Xeno-canto is to eventually represent sounds of all animals, meaning of all taxa, to subspecies level, of their complete repertoire, with all of the geographic variability, at all stages of development.The website of Xeno-canto (www.xeno-canto.org) was launched in 2005, and initially focussed on Neotropical birds. The scope of Xeno-canto has gradually widening and the Orthoptera sound collection was started in 2022. XC is run by the Xeno-canto Foundation for Nature Sounds in The Netherlands, with support from Naturalis Biodiversity Center. Please note that the Chiroptera sound dataset shared on GBIF is a subset of the entire collection that is available on https://xeno-canto.org/?gid=3. Only the recordings by recordists who have given their permission to share recording metadata with GBIF are shared here.
DOI: 10.15468/dl.pyng7g
title: Occurrence Download

description: A dataset containing 2061 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 {
 "not" : {
 "BasisOfRecord" : [
 "is one of (Fossil, Living Specimen)"
 ]
 }
 },
 "Year is greater than or equal to 1900",
 "TaxonKey is Hyperthelia dissoluta"
 ]
}

 The dataset includes 2061 records from 93 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0023722-260208012135463/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.2vx77b
title: Occurrence Download

description: A dataset containing 293 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Sphagnum strictum",
 "Country is one of (Norway)",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 "CoordinateUncertaintyInMeters is less than or equal to 1000",
 "Year is greater than or equal to 1986",
 "Year is less than or equal to 2025",
 {
 "not" : {
 "BasisOfRecord" : [
 "is Fossil"
 ]
 }
 },
 {
 "not" : {
 "BasisOfRecord" : [
 "is Machine Observation"
 ]
 }
 }
 ]
}

 The dataset includes 293 records from 7 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0023723-260208012135463/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.18149456
title: Spatial Transcriptomics Data for jazzPanda

description: This repository contains spatial transcriptomics datasets used in the jazzPanda study, including raw, vendor-distributed data files and processed data objects (e.g. Seurat and SpatialExperiment objects) generated to support the jazzPanda paper and its associated analyses. This record serves as an archival mirror of publicly available raw data to support transparency and reproducibility; all downstream analyses and results are described in the jazzPanda paper and implemented in the accompanying analysis repository (https://github.com/phipsonlab/jazzPanda_paper).

The included datasets originate from multiple commercial platforms, including 10x Genomics Xenium, NanoString CosMx, and Vizgen MERSCOPE, and encompass mouse brain as well as multiple human cancer and healthy tissue samples. The data were accessed from the respective vendor portals in early 2025.

Public data sources:

1) 10x Xenium Mouse brain data: https://www.10xgenomics.com/resources/datasets/fresh-frozen-mouse-brain-replicates-1-standard

2) 10x Xenium Human HER2+ breast cancer data: https://www.10xgenomics.com/products/xenium-in-situ/preview-dataset-human-breast

3) 10x Xenium Human lung cancer data: https://www.10xgenomics.com/resources/datasets/xenium-human-lung-preview-data-1-standard

4) Nanostring CosMx Human liver healthy and cancer data: https://nanostring.com/products/cosmx-spatial-molecular-imager/ffpe-dataset/human-liver-rna-ffpe-dataset/

5) Vizgen MERSCOPE Human breast cancer data: https://info.vizgen.com/ffpe-showcase?submissionGuid=c9a25730-3fe5-444b-bef8-1a74d51ddefb

Data reuse is subject to the original licensing and usage terms of the respective data providers.
DOI: 10.5281/zenodo.18149455
title: Spatial Transcriptomics Data for jazzPanda

description: This repository contains spatial transcriptomics datasets used in the jazzPanda study, including raw, vendor-distributed data files and processed data objects (e.g. Seurat and SpatialExperiment objects) generated to support the jazzPanda paper and its associated analyses. This record serves as an archival mirror of publicly available raw data to support transparency and reproducibility; all downstream analyses and results are described in the jazzPanda paper and implemented in the accompanying analysis repository (https://github.com/phipsonlab/jazzPanda_paper).

The included datasets originate from multiple commercial platforms, including 10x Genomics Xenium, NanoString CosMx, and Vizgen MERSCOPE, and encompass mouse brain as well as multiple human cancer and healthy tissue samples. The data were accessed from the respective vendor portals in early 2025.

Public data sources:

1) 10x Xenium Mouse brain data: https://www.10xgenomics.com/resources/datasets/fresh-frozen-mouse-brain-replicates-1-standard

2) 10x Xenium Human HER2+ breast cancer data: https://www.10xgenomics.com/products/xenium-in-situ/preview-dataset-human-breast

3) 10x Xenium Human lung cancer data: https://www.10xgenomics.com/resources/datasets/xenium-human-lung-preview-data-1-standard

4) Nanostring CosMx Human liver healthy and cancer data: https://nanostring.com/products/cosmx-spatial-molecular-imager/ffpe-dataset/human-liver-rna-ffpe-dataset/

5) Vizgen MERSCOPE Human breast cancer data: https://info.vizgen.com/ffpe-showcase?submissionGuid=c9a25730-3fe5-444b-bef8-1a74d51ddefb

Data reuse is subject to the original licensing and usage terms of the respective data providers.
DOI: 10.15468/dl.7v6xz9
title: Occurrence Download

description: A dataset containing 33 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Sphagnum aongstroemii",
 "Country is one of (Norway)",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 "CoordinateUncertaintyInMeters is less than or equal to 1000",
 "Year is greater than or equal to 1986",
 "Year is less than or equal to 2025",
 {
 "not" : {
 "BasisOfRecord" : [
 "is Fossil"
 ]
 }
 },
 {
 "not" : {
 "BasisOfRecord" : [
 "is Machine Observation"
 ]
 }
 }
 ]
}

 The dataset includes 33 records from 3 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0023724-260208012135463/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.avaeau
title: Occurrence Download

description: A dataset containing 100035 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (Thalassarche melanophris)",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "OccurrenceStatus is Present",
 "BasisOfRecord is Human Observation",
 "Year is greater than or equal to 1980",
 "Year is less than or equal to 2024",
 {
 "or" : [
 "CoordinateUncertaintyInMeters is less than 1000",
 "CoordinateUncertaintyInMeters is null"
 ]
 },
 "Geometry POLYGON ((-180 -89.99893, 180 -89.99893, 180 83.59961, -180 83.59961, -180 -89.99893))"
 ]
}

 The dataset includes 100035 records from 77 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0023698-260208012135463/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.31352794
title: Supplementary Material for: Real-World Multimodal Day-Care Intervention for Mild Cognitive Impairment with Lewy Bodies: A Prospective 3-Year Comparative Cognitive Trajectory Study

description: Background: Mild cognitive impairment with Lewy bodies (MCI-LB) is generally associated with more rapid cognitive decline than mild cognitive impairment due to Alzheimer’s disease (MCI-AD). However, evidence regarding the potential cognitive trajectories of individuals with MCI-LB participating in structured non-pharmacological multimodal programs remains limited. 
Objective: To preliminarily examine cognitive changes over time among individuals with MCI-LB and MCI-AD undergoing a multimodal intervention. 
Methods: Conducted at the University of Tsukuba Hospital between April 2013 and February 2020, this prospective study enrolled 74 participants (MCI-LB: 14; MCI-AD: 60) in the Cognitive Improvement Day-Care (CIDC) program. The CIDC was a multimodal intervention offering structured sessions including physical exercise, cognitive training, music therapy, and art-based activities. Participants attended the program, mostly once a week, and underwent annual cognitive assessments for up to three years using the Mini-Mental State Examination (MMSE-J). Linear mixed-effects models were used to analyze longitudinal changes in MMSE-J scores. 
Results: The overall annual cognitive decline was –0.36 points/year (95% CI: –0.63, 0.10). The annual decline was –0.44 points/year (95% CI: –0.95, 0.06) for the MCI-LB group and –0.34 points/year (95% CI: –0.64, -0.03) for the MCI-AD group. No significant group-by-time interaction was observed over the three-year follow-up (P = 0.97). 
Conclusions: These findings suggest that individuals with MCI-LB exhibited longitudinal cognitive trajectories under a structured multimodal intervention that were comparable to those observed in individuals with MCI-AD, at least as assessed by the MMSE-J. Future studies with larger samples and more detailed cognitive assessments are needed to clarify potential subtype-specific responses.
DOI: 10.6084/m9.figshare.31352794.v1
title: Supplementary Material for: Real-World Multimodal Day-Care Intervention for Mild Cognitive Impairment with Lewy Bodies: A Prospective 3-Year Comparative Cognitive Trajectory Study

description: Background: Mild cognitive impairment with Lewy bodies (MCI-LB) is generally associated with more rapid cognitive decline than mild cognitive impairment due to Alzheimer’s disease (MCI-AD). However, evidence regarding the potential cognitive trajectories of individuals with MCI-LB participating in structured non-pharmacological multimodal programs remains limited. 
Objective: To preliminarily examine cognitive changes over time among individuals with MCI-LB and MCI-AD undergoing a multimodal intervention. 
Methods: Conducted at the University of Tsukuba Hospital between April 2013 and February 2020, this prospective study enrolled 74 participants (MCI-LB: 14; MCI-AD: 60) in the Cognitive Improvement Day-Care (CIDC) program. The CIDC was a multimodal intervention offering structured sessions including physical exercise, cognitive training, music therapy, and art-based activities. Participants attended the program, mostly once a week, and underwent annual cognitive assessments for up to three years using the Mini-Mental State Examination (MMSE-J). Linear mixed-effects models were used to analyze longitudinal changes in MMSE-J scores. 
Results: The overall annual cognitive decline was –0.36 points/year (95% CI: –0.63, 0.10). The annual decline was –0.44 points/year (95% CI: –0.95, 0.06) for the MCI-LB group and –0.34 points/year (95% CI: –0.64, -0.03) for the MCI-AD group. No significant group-by-time interaction was observed over the three-year follow-up (P = 0.97). 
Conclusions: These findings suggest that individuals with MCI-LB exhibited longitudinal cognitive trajectories under a structured multimodal intervention that were comparable to those observed in individuals with MCI-AD, at least as assessed by the MMSE-J. Future studies with larger samples and more detailed cognitive assessments are needed to clarify potential subtype-specific responses.
DOI: 10.6084/m9.figshare.31352797
title: Supplementary Material for: Design and Rationale of the EARMI Trial: A Randomized Controlled Trial on Early-Phase Cardiac Rehabilitation Post-PCI in AMI Patients

description: Background: Cardiac rehabilitation (CR) is a key component of secondary prevention in patients with coronary artery disease. However, the optimal timing, structure, and feasibility of EBCR initiated during hospitalization following acute myocardial infarction (AMI) treated with percutaneous coronary intervention (PCI) remain underexplored.
Methods: The EARMI trial is a multicenter, randomized, parallel-group controlled trial designed to assess the efficacy and safety of a structured, phase-specific CR program initiated within 24 hours post-PCI. This intervention will be implemented across three distinct recovery phases: intensive care unit (ICU), hospital ward, and home-based rehabilitation. Eighty AMI patients will be randomized (1:1) to receive exercise-based CR or usual care. The intervention consists of progressive aerobic and resistance training, with individualized progression tailored to each patient’s clinical status. The primary outcomes include left ventricular function (measured by LVEF, LVEDD, LVESD), exercise capacity (assessed by VO2 peak, 6MWT, and METs), and autonomic function (evaluated by HRV). Secondary outcomes include health-related quality of life (assessed by SF-36), metabolic markers, and major adverse cardiovascular events (MACE). 
Expected Results: Over the 12 weeks intervention period, the study is powered to detect clinically significant improvements in myocardial function, exercise tolerance, and autonomic regulation. Safety and feasibility will be assessed through continuous surveillance of adverse events and quantification of adherence rates.
Conclusion: The EARMI trial is one of the first studies to evaluate the impact of initiating a structured early-phase CR model during the acute phase of AMI. The findings may provide crucial insights into scalable, time-sensitive rehabilitation strategies for post-AMI recovery and contribute to the integration of CR into modern cardiovascular care pathways.
DOI: 10.6084/m9.figshare.31352797.v1
title: Supplementary Material for: Design and Rationale of the EARMI Trial: A Randomized Controlled Trial on Early-Phase Cardiac Rehabilitation Post-PCI in AMI Patients

description: Background: Cardiac rehabilitation (CR) is a key component of secondary prevention in patients with coronary artery disease. However, the optimal timing, structure, and feasibility of EBCR initiated during hospitalization following acute myocardial infarction (AMI) treated with percutaneous coronary intervention (PCI) remain underexplored.
Methods: The EARMI trial is a multicenter, randomized, parallel-group controlled trial designed to assess the efficacy and safety of a structured, phase-specific CR program initiated within 24 hours post-PCI. This intervention will be implemented across three distinct recovery phases: intensive care unit (ICU), hospital ward, and home-based rehabilitation. Eighty AMI patients will be randomized (1:1) to receive exercise-based CR or usual care. The intervention consists of progressive aerobic and resistance training, with individualized progression tailored to each patient’s clinical status. The primary outcomes include left ventricular function (measured by LVEF, LVEDD, LVESD), exercise capacity (assessed by VO2 peak, 6MWT, and METs), and autonomic function (evaluated by HRV). Secondary outcomes include health-related quality of life (assessed by SF-36), metabolic markers, and major adverse cardiovascular events (MACE). 
Expected Results: Over the 12 weeks intervention period, the study is powered to detect clinically significant improvements in myocardial function, exercise tolerance, and autonomic regulation. Safety and feasibility will be assessed through continuous surveillance of adverse events and quantification of adherence rates.
Conclusion: The EARMI trial is one of the first studies to evaluate the impact of initiating a structured early-phase CR model during the acute phase of AMI. The findings may provide crucial insights into scalable, time-sensitive rehabilitation strategies for post-AMI recovery and contribute to the integration of CR into modern cardiovascular care pathways.
DOI: 10.6084/m9.figshare.31352800
title: Supplementary Material for: Multidomain Developmental Indicators in 4–9-Year-Old Children with Oral Motor and Speech Sound Disorders

description: Background:
Persistent speech sound disorders (SSD) are common in childhood and affect communication, literacy, and social development. Identifying risk indicators (RIs) and predictors for atypical oral motor and speech development is crucial for early intervention. This study examined medical, developmental, oral-behavioural, and hereditary RIs in children with SSD and compared diagnostic subgroups to typically developing peers. 
Method:
A clinical cohort of 198 children (ages 4–9) referred for specialist assessment was compared to 77 age-matched controls. Children were classified into four subgroups: MSD+ (motor speech disorder, with/without oral motor developmental delay and/or language-oriented disorder), LD+ODD (language-oriented disorder with oral motor developmental delay, no MSD), ODD-only, and LD-only. Thirty-one RIs were analysed using Chi-square or Fisher’s exact tests with Bonferroni correction. Multivariate binary backwards logistic regression identified predictors of group membership (clinical vs. control).
Results:
The clinical group showed 11 of 31 RIs significantly more prevalent than controls (p &lt; .0016). Children with multiple diagnoses (MSD+ and LD+ODD) had the highest RI counts (12 and 11, respectively), while single-diagnosis groups showed fewer RIs (LD-only: 2; ODD-only: 6). Significant RIs included medical (adenoid surgery, pulmonary disease), oral behaviours (mouth stimuli, selective eating), and developmental indicators (abnormal or absent crawling, delayed bladder control, fine/gross motor delay, non-canonical babble, poor attention during story listening). Family history of speech/language delay and literacy difficulties was also significant. The regression model demonstrated an excellent fit (Nagelkerke R² = .69; classification accuracy = 86.8%). Strong predictors for having an oral motor and/or a speech disorder included adenoid surgery (OR = 63.49), ear tube surgery (OR = 60.53), mouth stimuli behaviours (OR = 9.77), non-canonical babble (OR = 10.45), abnormal crawling (OR = 12.20), and family history of speech/language delay (OR = 9.89).
Conclusion:
Children with SSD often present multiple RIs across medical, developmental, oral-behavioural, and hereditary domains, especially those with combined diagnoses. Findings highlight the need for early, multidomain assessment and suggest that RIs such as oral motor behaviours and early developmental delays may inform screening and intervention strategies, supporting clinicians in identifying children who could benefit from tailored early intervention.
DOI: 10.6084/m9.figshare.31352800.v1
title: Supplementary Material for: Multidomain Developmental Indicators in 4–9-Year-Old Children with Oral Motor and Speech Sound Disorders

description: Background:
Persistent speech sound disorders (SSD) are common in childhood and affect communication, literacy, and social development. Identifying risk indicators (RIs) and predictors for atypical oral motor and speech development is crucial for early intervention. This study examined medical, developmental, oral-behavioural, and hereditary RIs in children with SSD and compared diagnostic subgroups to typically developing peers. 
Method:
A clinical cohort of 198 children (ages 4–9) referred for specialist assessment was compared to 77 age-matched controls. Children were classified into four subgroups: MSD+ (motor speech disorder, with/without oral motor developmental delay and/or language-oriented disorder), LD+ODD (language-oriented disorder with oral motor developmental delay, no MSD), ODD-only, and LD-only. Thirty-one RIs were analysed using Chi-square or Fisher’s exact tests with Bonferroni correction. Multivariate binary backwards logistic regression identified predictors of group membership (clinical vs. control).
Results:
The clinical group showed 11 of 31 RIs significantly more prevalent than controls (p &lt; .0016). Children with multiple diagnoses (MSD+ and LD+ODD) had the highest RI counts (12 and 11, respectively), while single-diagnosis groups showed fewer RIs (LD-only: 2; ODD-only: 6). Significant RIs included medical (adenoid surgery, pulmonary disease), oral behaviours (mouth stimuli, selective eating), and developmental indicators (abnormal or absent crawling, delayed bladder control, fine/gross motor delay, non-canonical babble, poor attention during story listening). Family history of speech/language delay and literacy difficulties was also significant. The regression model demonstrated an excellent fit (Nagelkerke R² = .69; classification accuracy = 86.8%). Strong predictors for having an oral motor and/or a speech disorder included adenoid surgery (OR = 63.49), ear tube surgery (OR = 60.53), mouth stimuli behaviours (OR = 9.77), non-canonical babble (OR = 10.45), abnormal crawling (OR = 12.20), and family history of speech/language delay (OR = 9.89).
Conclusion:
Children with SSD often present multiple RIs across medical, developmental, oral-behavioural, and hereditary domains, especially those with combined diagnoses. Findings highlight the need for early, multidomain assessment and suggest that RIs such as oral motor behaviours and early developmental delays may inform screening and intervention strategies, supporting clinicians in identifying children who could benefit from tailored early intervention.
DOI: 10.15468/dl.b48a56
title: Occurrence Download

description: A dataset containing 262 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 {
 "not" : {
 "BasisOfRecord" : [
 "is one of (Fossil, Living Specimen)"
 ]
 }
 },
 "Year is greater than or equal to 1900",
 "TaxonKey is Imperata brevifolia"
 ]
}

 The dataset includes 262 records from 31 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0023725-260208012135463/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.nkr57d
title: Occurrence Download

description: A dataset containing 64 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Sphagnum annulatum",
 "Country is one of (Norway)",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 "CoordinateUncertaintyInMeters is less than or equal to 1000",
 "Year is greater than or equal to 1986",
 "Year is less than or equal to 2025",
 {
 "not" : {
 "BasisOfRecord" : [
 "is Fossil"
 ]
 }
 },
 {
 "not" : {
 "BasisOfRecord" : [
 "is Machine Observation"
 ]
 }
 }
 ]
}

 The dataset includes 64 records from 4 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0023727-260208012135463/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.spasj4
title: Occurrence Download

description: A dataset containing 46325 species occurrences available in GBIF matching the query:
{
 "and" : [
 "BasisOfRecord is one of (Human Observation, Specimen)",
 "Country is United States of America",
 "OccurrenceStatus is Present",
 "TaxonKey is Cornus florida"
 ]
}

 The dataset includes 46325 records from 253 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0023726-260208012135463/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.